SMARCB1 (INI1) 欠乏症の胸内腫瘍が,非小細胞肺がんの化学療法に反応せず,急速に進行した症例
Yutaro Moriyasu1, Takeshi Tsuda1, Kei Matsuyama1
1Department of Respiratory Medicine, Toyama Prefectural Central Hospital, Toyama, Japan.
Case reports in oncology
|August 29, 2025
まとめ
SMARCB1欠乏症の胸内腫瘍は珍しい,攻撃的な腫瘍です. このケースでは 誤って小細胞肺がんと診断され 治療にも関わらず 急速に進行し 死に至りました
科学分野:
- 腫瘍学
- 病理学について
背景:
- SMARCB1 (INI1) 欠乏症の胸内腫瘍は稀であり,非常に悪性である.
- これらの腫瘍の正確な診断と理解は 効果的な管理に不可欠です
さらに関連する動画
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.5K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
関連する概念動画
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
